Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded $1.3 million to 23 organizations through its Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) Program. Grant recipients are committed to improving colorectal cancer (CRC) screening rates and making healthcare more accessible, with a focus on medically underserved populations.

CRC remains the second-leading cause of cancer death in the United States.1 The disease is more treatable if caught in early stages,1 yet an estimated 60 million average-risk adults remain unscreened in the United States.2,3*

The most marginalized patient populations often go unscreened for CRC, which is one reason the disease disproportionately affects certain socioeconomic groups, races, and regions in the United States.3 Half of premature CRC deaths are related to racial, ethnic, socioeconomic and geographic inequalities.4

Click here to read the full article.